Literature DB >> 25518400

[Kawasaki disease and innate immunity].

Toshiro Hara.   

Abstract

Kawasaki disease (KD) is an acute self-limited systemic vasculitis, and could develop in association with innate immune disorders. An innate immune system appears to play a key role in the development of KD, because pathogen-associated molecular patterns(PAMPs) and damage-associated molecular patterns(DAMPs) are elevated in the sera at acute phase KD, and oral administration of innate immune Nod1 ligand induces KD-like coronary arteritis in mice. PAMPs can be produced massively from microbes in a certain condition. DAMPs are produced from the host cells by the stimulation of PAMPs. We propose a hypothesis that PAMPs and DAMPs activate innate immune system and vascular cells through innate immune pattern recognition receptors(PRR) to release chemokines and cytokines, and induce KD in genetically predisposed individuals.

Entities:  

Mesh:

Year:  2014        PMID: 25518400

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  4 in total

1.  New biomarkers of Kawasaki disease identified by urine proteomic analysis.

Authors:  Hui-Min Hu; Hong-Wu Du; Jia-Wen Cui; De-Qin Feng; Zhong-Dong Du
Journal:  FEBS Open Bio       Date:  2018-12-20       Impact factor: 2.693

2.  Patterns of Presentation of SARS-CoV-2 Infection in Children. Experience at the Italian Epicentre of the Pandemic.

Authors:  Angelo Mazza; Angelo Di Giorgio; Laura Martelli; Ciretta Pelliccia; Moira Alessandra Pinotti; Vera Quadri; Lucio Verdoni; Alice Decio; Maurizio Ruggeri; Lorenzo D'Antiga
Journal:  Front Pediatr       Date:  2021-01-28       Impact factor: 3.418

Review 3.  Recent Advances in Kawasaki Disease.

Authors:  Kyu Yeun Kim; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2016-01       Impact factor: 2.759

4.  ITPKC and SLC11A1 Gene Polymorphisms and Gene-Gene Interactions in Korean Patients with Kawasaki Disease.

Authors:  Kyu Yeun Kim; Yoon Sun Bae; Woohyuk Ji; Dongjik Shin; Ho Seong Kim; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2018-01       Impact factor: 2.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.